| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Scientific Officer
1 company
Dunne Michael W. is a Director at Iterum Therapeutics plc. Recent SEC Form 4 filings include 10 buys and 1 sell.
Estimated insider holdings value: $7K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | ITRM Iterum Therapeutics Plc | Director | Buy | 6,000 | $0.37 | $2,191.20 | +2.6% | -35.3% | - | |
| Aug 8, 2025 | ITRM Iterum Therapeutics Plc | Director | Buy | 15,000 | $0.72 | $10,854.00 | +6.8% | -18.0% | - | |
| Dec 22, 2023 | ITRM Iterum Therapeutics Plc | Director | Buy | 25,000 | $1.40 | $35,000.00 | +28.2% | +12.9% | +26.4% | |
| Dec 18, 2023 | ITRM Iterum Therapeutics Plc | Director | Buy | 10,000 | $1.84 | $18,442.00 | +12.7% | -6.3% | +5.2% | |
| Nov 22, 2023 | ITRM Iterum Therapeutics Plc | Director | Buy | 20,000 | $2.03 | $40,690.00 | +34.0% | -29.0% | -14.5% | |
| Sep 7, 2022 | ITRM Iterum Therapeutics Plc | Director | Buy | 10,000 | $2.22 | $22,200.00 | +39.1% | -42.0% | -63.6% | |
| Jan 26, 2021 | ITRM Iterum Therapeutics Plc | Director | Sell | 33,143 | $1.73 | $57,337.39 | -11.4% | - | - | |
| Oct 27, 2020 | ITRM Iterum Therapeutics Plc | Chief Scientific Officer | Buy | 61,540 | $0.00 | - | +41.6% | - | - | |
| Sep 4, 2018 | ITRM Iterum Therapeutics Plc | Chief Scientific Officer | Buy | 500 | $10.00 | $5,000.00 | +0.3% | - | - | |
| Aug 27, 2018 | ITRM Iterum Therapeutics Plc | Chief Scientific Officer | Buy | 1,000 | $10.00 | $10,000.00 | +0.3% | - | - |